• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Department of Health and Human Services (HHS)

Robert Kennedy Jr ARPA-H
Biotech

ARPA-H bets $4.9 million on ibogaine to treat PTSD in veterans

The funding will come over a five-year period from ARPA-H and will include a a focus on veterans.
Marissa Russo Nov 12, 2026 2:56pm
Robert Kennedy Jr ARPA-H clinical trials

ARPA-H unveils Surpass program to accelerate clinical trials

Oct 7, 2026 11:25am
accelerated

FDA launches pilot program to speed up sluggish phase 1 trials

Sep 15, 2026 2:09pm
HHS headquarters as seen on April 02 2025

NIH joins Trump’s $5B AI mission with biomedical research push

Jul 22, 2026 2:43pm
Kyle Diamantas

HHS unveils plan to speed up ph. 1 trials by 6 to 12 months

Jun 22, 2026 12:10pm
Open door symbolizing exit
Favicon Fierce Pharma

CDER chief Høeg and CBER's Szarama exiting FDA posts

May 15, 2026 1:44pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings